Management of Disseminated Intravascular Coagulation in Acute-on-Chronic Liver Failure

Pathophysiology and Diagnosis

Standard coagulation tests like INR have poor correlation with bleeding risk in critically ill cirrhotic patients as they only measure procoagulant factors without accounting for concurrent anticoagulant deficiencies 2
Viscoelastic testing provides more functional evaluation of coagulation but optimal cutoffs for guiding therapy in ACLF are not established 2

Treatment of the underlying cause of ACLF is the fundamental intervention, according to the Journal of Hepatology 3
Early identification and management of precipitating factors such as bacterial infections, GI bleeding, or drug toxicity is crucial for patient survival 3
Patients should ideally be admitted to intensive care or intermediate care units, with early referral to transplant centers if appropriate, as recommended by the Journal of Hepatology 3
In patients with active bleeding, maintain platelet count >50×10⁹/L 1
In patients with active bleeding, administer 15-30 mL/kg of plasma fresh frozen plasma (PFC) 1
Consider fibrinogen replacement with cryoprecipitate or fibrinogen concentrate if levels remain <1.5 g/L despite PFC 1
Avoid prophylactic transfusions based solely on laboratory values, as per Praxis Medical Insights 1
Consider platelet transfusion only if high risk of bleeding and platelet count <20×10⁹/L 1

Provide appropriate organ support as needed, such as vasopressors for hypotension, ventilation for respiratory failure, etc., as recommended by the Journal of Hepatology 3
Consider renal replacement therapy for patients with acute kidney injury meeting criteria for this treatment, according to the Journal of Hepatology 3
Extracorporeal liver support systems have not shown significant survival benefit in ACLF and are not recommended by the Journal of Hepatology 3

Implement infection prevention measures as infections can trigger or worsen both ACLF and DIC, as suggested by Hepatology 2
Remove unnecessary catheters, limit hospital stay, ensure vaccines are up to date, and stop unnecessary medications like PPIs, as recommended by Hepatology 2
Provide early and appropriate antibiotic therapy for infections, with de-escalation once culture results return, according to Hepatology 2